Global Huntington Disease Protein Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Huntington Disease Protein will have significant change from previous year. According to our (LP Information) latest study, the global Huntington Disease Protein market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Huntington Disease Protein market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Huntington Disease Protein market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Huntington Disease Protein market, reaching US$ million by the year 2028. As for the Europe Huntington Disease Protein landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Huntington Disease Protein players cover AFFiRiS AG, Ionis Pharmaceuticals, Inc., Neurimmune Holding AG, and nLife Therapeutics, S.L., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Huntington Disease Protein market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Huntington Disease Protein will have significant change from previous year. According to our (LP Information) latest study, the global Huntington Disease Protein market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Huntington Disease Protein market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Huntington Disease Protein market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Huntington Disease Protein market, reaching US$ million by the year 2028. As for the Europe Huntington Disease Protein landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Huntington Disease Protein players cover AFFiRiS AG, Ionis Pharmaceuticals, Inc., Neurimmune Holding AG, and nLife Therapeutics, S.L., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Huntington Disease Protein market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- NI-302
- NLF-HD
- P-301905
- IONIS-HTTRx
- Others
- Alzheimer's Disease
- Kennedy's Disease
- Spinocerebellar Ataxia
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AFFiRiS AG
- Ionis Pharmaceuticals, Inc.
- Neurimmune Holding AG
- nLife Therapeutics, S.L.
- reMYND NV
- Sangamo BioSciences, Inc.
- UniQure N.V.
- Voyager Therapeutics, Inc.
- Vybion, Inc.
- WAVE Life Sciences Ltd.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Huntington Disease Protein Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Huntington Disease Protein by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Huntington Disease Protein by Country/Region, 2017, 2022 & 2028
2.2 Huntington Disease Protein Segment by Type
2.2.1 NI-302
2.2.2 NLF-HD
2.2.3 P-301905
2.2.4 IONIS-HTTRx
2.2.5 Others
2.3 Huntington Disease Protein Sales by Type
2.3.1 Global Huntington Disease Protein Sales Market Share by Type (2017-2022)
2.3.2 Global Huntington Disease Protein Revenue and Market Share by Type (2017-2022)
2.3.3 Global Huntington Disease Protein Sale Price by Type (2017-2022)
2.4 Huntington Disease Protein Segment by Application
2.4.1 Alzheimer's Disease
2.4.2 Kennedy's Disease
2.4.3 Spinocerebellar Ataxia
2.4.4 Others
2.5 Huntington Disease Protein Sales by Application
2.5.1 Global Huntington Disease Protein Sale Market Share by Application (2017-2022)
2.5.2 Global Huntington Disease Protein Revenue and Market Share by Application (2017-2022)
2.5.3 Global Huntington Disease Protein Sale Price by Application (2017-2022)
3 GLOBAL HUNTINGTON DISEASE PROTEIN BY COMPANY
3.1 Global Huntington Disease Protein Breakdown Data by Company
3.1.1 Global Huntington Disease Protein Annual Sales by Company (2020-2022)
3.1.2 Global Huntington Disease Protein Sales Market Share by Company (2020-2022)
3.2 Global Huntington Disease Protein Annual Revenue by Company (2020-2022)
3.2.1 Global Huntington Disease Protein Revenue by Company (2020-2022)
3.2.2 Global Huntington Disease Protein Revenue Market Share by Company (2020-2022)
3.3 Global Huntington Disease Protein Sale Price by Company
3.4 Key Manufacturers Huntington Disease Protein Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Huntington Disease Protein Product Location Distribution
3.4.2 Players Huntington Disease Protein Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HUNTINGTON DISEASE PROTEIN BY GEOGRAPHIC REGION
4.1 World Historic Huntington Disease Protein Market Size by Geographic Region (2017-2022)
4.1.1 Global Huntington Disease Protein Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Huntington Disease Protein Annual Revenue by Geographic Region
4.2 World Historic Huntington Disease Protein Market Size by Country/Region (2017-2022)
4.2.1 Global Huntington Disease Protein Annual Sales by Country/Region (2017-2022)
4.2.2 Global Huntington Disease Protein Annual Revenue by Country/Region
4.3 Americas Huntington Disease Protein Sales Growth
4.4 APAC Huntington Disease Protein Sales Growth
4.5 Europe Huntington Disease Protein Sales Growth
4.6 Middle East & Africa Huntington Disease Protein Sales Growth
5 AMERICAS
5.1 Americas Huntington Disease Protein Sales by Country
5.1.1 Americas Huntington Disease Protein Sales by Country (2017-2022)
5.1.2 Americas Huntington Disease Protein Revenue by Country (2017-2022)
5.2 Americas Huntington Disease Protein Sales by Type
5.3 Americas Huntington Disease Protein Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Huntington Disease Protein Sales by Region
6.1.1 APAC Huntington Disease Protein Sales by Region (2017-2022)
6.1.2 APAC Huntington Disease Protein Revenue by Region (2017-2022)
6.2 APAC Huntington Disease Protein Sales by Type
6.3 APAC Huntington Disease Protein Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Huntington Disease Protein by Country
7.1.1 Europe Huntington Disease Protein Sales by Country (2017-2022)
7.1.2 Europe Huntington Disease Protein Revenue by Country (2017-2022)
7.2 Europe Huntington Disease Protein Sales by Type
7.3 Europe Huntington Disease Protein Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Huntington Disease Protein by Country
8.1.1 Middle East & Africa Huntington Disease Protein Sales by Country (2017-2022)
8.1.2 Middle East & Africa Huntington Disease Protein Revenue by Country (2017-2022)
8.2 Middle East & Africa Huntington Disease Protein Sales by Type
8.3 Middle East & Africa Huntington Disease Protein Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Huntington Disease Protein
10.3 Manufacturing Process Analysis of Huntington Disease Protein
10.4 Industry Chain Structure of Huntington Disease Protein
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Huntington Disease Protein Distributors
11.3 Huntington Disease Protein Customer
12 WORLD FORECAST REVIEW FOR HUNTINGTON DISEASE PROTEIN BY GEOGRAPHIC REGION
12.1 Global Huntington Disease Protein Market Size Forecast by Region
12.1.1 Global Huntington Disease Protein Forecast by Region (2023-2028)
12.1.2 Global Huntington Disease Protein Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Huntington Disease Protein Forecast by Type
12.7 Global Huntington Disease Protein Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AFFiRiS AG
13.1.1 AFFiRiS AG Company Information
13.1.2 AFFiRiS AG Huntington Disease Protein Product Offered
13.1.3 AFFiRiS AG Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AFFiRiS AG Main Business Overview
13.1.5 AFFiRiS AG Latest Developments
13.2 Ionis Pharmaceuticals, Inc.
13.2.1 Ionis Pharmaceuticals, Inc. Company Information
13.2.2 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product Offered
13.2.3 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Ionis Pharmaceuticals, Inc. Main Business Overview
13.2.5 Ionis Pharmaceuticals, Inc. Latest Developments
13.3 Neurimmune Holding AG
13.3.1 Neurimmune Holding AG Company Information
13.3.2 Neurimmune Holding AG Huntington Disease Protein Product Offered
13.3.3 Neurimmune Holding AG Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Neurimmune Holding AG Main Business Overview
13.3.5 Neurimmune Holding AG Latest Developments
13.4 nLife Therapeutics, S.L.
13.4.1 nLife Therapeutics, S.L. Company Information
13.4.2 nLife Therapeutics, S.L. Huntington Disease Protein Product Offered
13.4.3 nLife Therapeutics, S.L. Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 nLife Therapeutics, S.L. Main Business Overview
13.4.5 nLife Therapeutics, S.L. Latest Developments
13.5 reMYND NV
13.5.1 reMYND NV Company Information
13.5.2 reMYND NV Huntington Disease Protein Product Offered
13.5.3 reMYND NV Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 reMYND NV Main Business Overview
13.5.5 reMYND NV Latest Developments
13.6 Sangamo BioSciences, Inc.
13.6.1 Sangamo BioSciences, Inc. Company Information
13.6.2 Sangamo BioSciences, Inc. Huntington Disease Protein Product Offered
13.6.3 Sangamo BioSciences, Inc. Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sangamo BioSciences, Inc. Main Business Overview
13.6.5 Sangamo BioSciences, Inc. Latest Developments
13.7 UniQure N.V.
13.7.1 UniQure N.V. Company Information
13.7.2 UniQure N.V. Huntington Disease Protein Product Offered
13.7.3 UniQure N.V. Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 UniQure N.V. Main Business Overview
13.7.5 UniQure N.V. Latest Developments
13.8 Voyager Therapeutics, Inc.
13.8.1 Voyager Therapeutics, Inc. Company Information
13.8.2 Voyager Therapeutics, Inc. Huntington Disease Protein Product Offered
13.8.3 Voyager Therapeutics, Inc. Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Voyager Therapeutics, Inc. Main Business Overview
13.8.5 Voyager Therapeutics, Inc. Latest Developments
13.9 Vybion, Inc.
13.9.1 Vybion, Inc. Company Information
13.9.2 Vybion, Inc. Huntington Disease Protein Product Offered
13.9.3 Vybion, Inc. Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Vybion, Inc. Main Business Overview
13.9.5 Vybion, Inc. Latest Developments
13.10 WAVE Life Sciences Ltd.
13.10.1 WAVE Life Sciences Ltd. Company Information
13.10.2 WAVE Life Sciences Ltd. Huntington Disease Protein Product Offered
13.10.3 WAVE Life Sciences Ltd. Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 WAVE Life Sciences Ltd. Main Business Overview
13.10.5 WAVE Life Sciences Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Huntington Disease Protein Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Huntington Disease Protein by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Huntington Disease Protein by Country/Region, 2017, 2022 & 2028
2.2 Huntington Disease Protein Segment by Type
2.2.1 NI-302
2.2.2 NLF-HD
2.2.3 P-301905
2.2.4 IONIS-HTTRx
2.2.5 Others
2.3 Huntington Disease Protein Sales by Type
2.3.1 Global Huntington Disease Protein Sales Market Share by Type (2017-2022)
2.3.2 Global Huntington Disease Protein Revenue and Market Share by Type (2017-2022)
2.3.3 Global Huntington Disease Protein Sale Price by Type (2017-2022)
2.4 Huntington Disease Protein Segment by Application
2.4.1 Alzheimer's Disease
2.4.2 Kennedy's Disease
2.4.3 Spinocerebellar Ataxia
2.4.4 Others
2.5 Huntington Disease Protein Sales by Application
2.5.1 Global Huntington Disease Protein Sale Market Share by Application (2017-2022)
2.5.2 Global Huntington Disease Protein Revenue and Market Share by Application (2017-2022)
2.5.3 Global Huntington Disease Protein Sale Price by Application (2017-2022)
3 GLOBAL HUNTINGTON DISEASE PROTEIN BY COMPANY
3.1 Global Huntington Disease Protein Breakdown Data by Company
3.1.1 Global Huntington Disease Protein Annual Sales by Company (2020-2022)
3.1.2 Global Huntington Disease Protein Sales Market Share by Company (2020-2022)
3.2 Global Huntington Disease Protein Annual Revenue by Company (2020-2022)
3.2.1 Global Huntington Disease Protein Revenue by Company (2020-2022)
3.2.2 Global Huntington Disease Protein Revenue Market Share by Company (2020-2022)
3.3 Global Huntington Disease Protein Sale Price by Company
3.4 Key Manufacturers Huntington Disease Protein Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Huntington Disease Protein Product Location Distribution
3.4.2 Players Huntington Disease Protein Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HUNTINGTON DISEASE PROTEIN BY GEOGRAPHIC REGION
4.1 World Historic Huntington Disease Protein Market Size by Geographic Region (2017-2022)
4.1.1 Global Huntington Disease Protein Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Huntington Disease Protein Annual Revenue by Geographic Region
4.2 World Historic Huntington Disease Protein Market Size by Country/Region (2017-2022)
4.2.1 Global Huntington Disease Protein Annual Sales by Country/Region (2017-2022)
4.2.2 Global Huntington Disease Protein Annual Revenue by Country/Region
4.3 Americas Huntington Disease Protein Sales Growth
4.4 APAC Huntington Disease Protein Sales Growth
4.5 Europe Huntington Disease Protein Sales Growth
4.6 Middle East & Africa Huntington Disease Protein Sales Growth
5 AMERICAS
5.1 Americas Huntington Disease Protein Sales by Country
5.1.1 Americas Huntington Disease Protein Sales by Country (2017-2022)
5.1.2 Americas Huntington Disease Protein Revenue by Country (2017-2022)
5.2 Americas Huntington Disease Protein Sales by Type
5.3 Americas Huntington Disease Protein Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Huntington Disease Protein Sales by Region
6.1.1 APAC Huntington Disease Protein Sales by Region (2017-2022)
6.1.2 APAC Huntington Disease Protein Revenue by Region (2017-2022)
6.2 APAC Huntington Disease Protein Sales by Type
6.3 APAC Huntington Disease Protein Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Huntington Disease Protein by Country
7.1.1 Europe Huntington Disease Protein Sales by Country (2017-2022)
7.1.2 Europe Huntington Disease Protein Revenue by Country (2017-2022)
7.2 Europe Huntington Disease Protein Sales by Type
7.3 Europe Huntington Disease Protein Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Huntington Disease Protein by Country
8.1.1 Middle East & Africa Huntington Disease Protein Sales by Country (2017-2022)
8.1.2 Middle East & Africa Huntington Disease Protein Revenue by Country (2017-2022)
8.2 Middle East & Africa Huntington Disease Protein Sales by Type
8.3 Middle East & Africa Huntington Disease Protein Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Huntington Disease Protein
10.3 Manufacturing Process Analysis of Huntington Disease Protein
10.4 Industry Chain Structure of Huntington Disease Protein
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Huntington Disease Protein Distributors
11.3 Huntington Disease Protein Customer
12 WORLD FORECAST REVIEW FOR HUNTINGTON DISEASE PROTEIN BY GEOGRAPHIC REGION
12.1 Global Huntington Disease Protein Market Size Forecast by Region
12.1.1 Global Huntington Disease Protein Forecast by Region (2023-2028)
12.1.2 Global Huntington Disease Protein Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Huntington Disease Protein Forecast by Type
12.7 Global Huntington Disease Protein Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AFFiRiS AG
13.1.1 AFFiRiS AG Company Information
13.1.2 AFFiRiS AG Huntington Disease Protein Product Offered
13.1.3 AFFiRiS AG Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AFFiRiS AG Main Business Overview
13.1.5 AFFiRiS AG Latest Developments
13.2 Ionis Pharmaceuticals, Inc.
13.2.1 Ionis Pharmaceuticals, Inc. Company Information
13.2.2 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product Offered
13.2.3 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Ionis Pharmaceuticals, Inc. Main Business Overview
13.2.5 Ionis Pharmaceuticals, Inc. Latest Developments
13.3 Neurimmune Holding AG
13.3.1 Neurimmune Holding AG Company Information
13.3.2 Neurimmune Holding AG Huntington Disease Protein Product Offered
13.3.3 Neurimmune Holding AG Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Neurimmune Holding AG Main Business Overview
13.3.5 Neurimmune Holding AG Latest Developments
13.4 nLife Therapeutics, S.L.
13.4.1 nLife Therapeutics, S.L. Company Information
13.4.2 nLife Therapeutics, S.L. Huntington Disease Protein Product Offered
13.4.3 nLife Therapeutics, S.L. Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 nLife Therapeutics, S.L. Main Business Overview
13.4.5 nLife Therapeutics, S.L. Latest Developments
13.5 reMYND NV
13.5.1 reMYND NV Company Information
13.5.2 reMYND NV Huntington Disease Protein Product Offered
13.5.3 reMYND NV Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 reMYND NV Main Business Overview
13.5.5 reMYND NV Latest Developments
13.6 Sangamo BioSciences, Inc.
13.6.1 Sangamo BioSciences, Inc. Company Information
13.6.2 Sangamo BioSciences, Inc. Huntington Disease Protein Product Offered
13.6.3 Sangamo BioSciences, Inc. Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sangamo BioSciences, Inc. Main Business Overview
13.6.5 Sangamo BioSciences, Inc. Latest Developments
13.7 UniQure N.V.
13.7.1 UniQure N.V. Company Information
13.7.2 UniQure N.V. Huntington Disease Protein Product Offered
13.7.3 UniQure N.V. Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 UniQure N.V. Main Business Overview
13.7.5 UniQure N.V. Latest Developments
13.8 Voyager Therapeutics, Inc.
13.8.1 Voyager Therapeutics, Inc. Company Information
13.8.2 Voyager Therapeutics, Inc. Huntington Disease Protein Product Offered
13.8.3 Voyager Therapeutics, Inc. Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Voyager Therapeutics, Inc. Main Business Overview
13.8.5 Voyager Therapeutics, Inc. Latest Developments
13.9 Vybion, Inc.
13.9.1 Vybion, Inc. Company Information
13.9.2 Vybion, Inc. Huntington Disease Protein Product Offered
13.9.3 Vybion, Inc. Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Vybion, Inc. Main Business Overview
13.9.5 Vybion, Inc. Latest Developments
13.10 WAVE Life Sciences Ltd.
13.10.1 WAVE Life Sciences Ltd. Company Information
13.10.2 WAVE Life Sciences Ltd. Huntington Disease Protein Product Offered
13.10.3 WAVE Life Sciences Ltd. Huntington Disease Protein Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 WAVE Life Sciences Ltd. Main Business Overview
13.10.5 WAVE Life Sciences Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Huntington Disease Protein Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Huntington Disease Protein Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of NI-302
Table 4. Major Players of NLF-HD
Table 5. Major Players of P-301905
Table 6. Major Players of IONIS-HTTRx
Table 7. Major Players of Others
Table 8. Global Huntington Disease Protein Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Huntington Disease Protein Sales Market Share by Type (2017-2022)
Table 10. Global Huntington Disease Protein Revenue by Type (2017-2022) & ($ million)
Table 11. Global Huntington Disease Protein Revenue Market Share by Type (2017-2022)
Table 12. Global Huntington Disease Protein Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Huntington Disease Protein Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Huntington Disease Protein Sales Market Share by Application (2017-2022)
Table 15. Global Huntington Disease Protein Revenue by Application (2017-2022)
Table 16. Global Huntington Disease Protein Revenue Market Share by Application (2017-2022)
Table 17. Global Huntington Disease Protein Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Huntington Disease Protein Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Huntington Disease Protein Sales Market Share by Company (2020-2022)
Table 20. Global Huntington Disease Protein Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Huntington Disease Protein Revenue Market Share by Company (2020-2022)
Table 22. Global Huntington Disease Protein Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Huntington Disease Protein Producing Area Distribution and Sales Area
Table 24. Players Huntington Disease Protein Products Offered
Table 25. Huntington Disease Protein Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Huntington Disease Protein Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Huntington Disease Protein Sales Market Share Geographic Region (2017-2022)
Table 30. Global Huntington Disease Protein Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Huntington Disease Protein Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Huntington Disease Protein Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Huntington Disease Protein Sales Market Share by Country/Region (2017-2022)
Table 34. Global Huntington Disease Protein Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Huntington Disease Protein Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Huntington Disease Protein Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Huntington Disease Protein Sales Market Share by Country (2017-2022)
Table 38. Americas Huntington Disease Protein Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Huntington Disease Protein Revenue Market Share by Country (2017-2022)
Table 40. Americas Huntington Disease Protein Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Huntington Disease Protein Sales Market Share by Type (2017-2022)
Table 42. Americas Huntington Disease Protein Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Huntington Disease Protein Sales Market Share by Application (2017-2022)
Table 44. APAC Huntington Disease Protein Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Huntington Disease Protein Sales Market Share by Region (2017-2022)
Table 46. APAC Huntington Disease Protein Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Huntington Disease Protein Revenue Market Share by Region (2017-2022)
Table 48. APAC Huntington Disease Protein Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Huntington Disease Protein Sales Market Share by Type (2017-2022)
Table 50. APAC Huntington Disease Protein Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Huntington Disease Protein Sales Market Share by Application (2017-2022)
Table 52. Europe Huntington Disease Protein Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Huntington Disease Protein Sales Market Share by Country (2017-2022)
Table 54. Europe Huntington Disease Protein Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Huntington Disease Protein Revenue Market Share by Country (2017-2022)
Table 56. Europe Huntington Disease Protein Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Huntington Disease Protein Sales Market Share by Type (2017-2022)
Table 58. Europe Huntington Disease Protein Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Huntington Disease Protein Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Huntington Disease Protein Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Huntington Disease Protein Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Huntington Disease Protein Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Huntington Disease Protein Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Huntington Disease Protein Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Huntington Disease Protein Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Huntington Disease Protein Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Huntington Disease Protein Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Huntington Disease Protein
Table 69. Key Market Challenges & Risks of Huntington Disease Protein
Table 70. Key Industry Trends of Huntington Disease Protein
Table 71. Huntington Disease Protein Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Huntington Disease Protein Distributors List
Table 74. Huntington Disease Protein Customer List
Table 75. Global Huntington Disease Protein Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Huntington Disease Protein Sales Market Forecast by Region
Table 77. Global Huntington Disease Protein Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Huntington Disease Protein Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Huntington Disease Protein Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Huntington Disease Protein Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Huntington Disease Protein Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Huntington Disease Protein Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Huntington Disease Protein Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Huntington Disease Protein Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Huntington Disease Protein Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Huntington Disease Protein Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Huntington Disease Protein Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Huntington Disease Protein Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Huntington Disease Protein Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Huntington Disease Protein Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Huntington Disease Protein Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Huntington Disease Protein Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Huntington Disease Protein Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Huntington Disease Protein Revenue Market Share Forecast by Application (2023-2028)
Table 95. AFFiRiS AG Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 96. AFFiRiS AG Huntington Disease Protein Product Offered
Table 97. AFFiRiS AG Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. AFFiRiS AG Main Business
Table 99. AFFiRiS AG Latest Developments
Table 100. Ionis Pharmaceuticals, Inc. Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 101. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product Offered
Table 102. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Ionis Pharmaceuticals, Inc. Main Business
Table 104. Ionis Pharmaceuticals, Inc. Latest Developments
Table 105. Neurimmune Holding AG Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 106. Neurimmune Holding AG Huntington Disease Protein Product Offered
Table 107. Neurimmune Holding AG Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Neurimmune Holding AG Main Business
Table 109. Neurimmune Holding AG Latest Developments
Table 110. nLife Therapeutics, S.L. Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 111. nLife Therapeutics, S.L. Huntington Disease Protein Product Offered
Table 112. nLife Therapeutics, S.L. Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. nLife Therapeutics, S.L. Main Business
Table 114. nLife Therapeutics, S.L. Latest Developments
Table 115. reMYND NV Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 116. reMYND NV Huntington Disease Protein Product Offered
Table 117. reMYND NV Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. reMYND NV Main Business
Table 119. reMYND NV Latest Developments
Table 120. Sangamo BioSciences, Inc. Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 121. Sangamo BioSciences, Inc. Huntington Disease Protein Product Offered
Table 122. Sangamo BioSciences, Inc. Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. Sangamo BioSciences, Inc. Main Business
Table 124. Sangamo BioSciences, Inc. Latest Developments
Table 125. UniQure N.V. Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 126. UniQure N.V. Huntington Disease Protein Product Offered
Table 127. UniQure N.V. Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. UniQure N.V. Main Business
Table 129. UniQure N.V. Latest Developments
Table 130. Voyager Therapeutics, Inc. Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 131. Voyager Therapeutics, Inc. Huntington Disease Protein Product Offered
Table 132. Voyager Therapeutics, Inc. Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. Voyager Therapeutics, Inc. Main Business
Table 134. Voyager Therapeutics, Inc. Latest Developments
Table 135. Vybion, Inc. Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 136. Vybion, Inc. Huntington Disease Protein Product Offered
Table 137. Vybion, Inc. Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 138. Vybion, Inc. Main Business
Table 139. Vybion, Inc. Latest Developments
Table 140. WAVE Life Sciences Ltd. Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 141. WAVE Life Sciences Ltd. Huntington Disease Protein Product Offered
Table 142. WAVE Life Sciences Ltd. Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 143. WAVE Life Sciences Ltd. Main Business
Table 144. WAVE Life Sciences Ltd. Latest Developments
Table 1. Huntington Disease Protein Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Huntington Disease Protein Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of NI-302
Table 4. Major Players of NLF-HD
Table 5. Major Players of P-301905
Table 6. Major Players of IONIS-HTTRx
Table 7. Major Players of Others
Table 8. Global Huntington Disease Protein Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Huntington Disease Protein Sales Market Share by Type (2017-2022)
Table 10. Global Huntington Disease Protein Revenue by Type (2017-2022) & ($ million)
Table 11. Global Huntington Disease Protein Revenue Market Share by Type (2017-2022)
Table 12. Global Huntington Disease Protein Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Huntington Disease Protein Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Huntington Disease Protein Sales Market Share by Application (2017-2022)
Table 15. Global Huntington Disease Protein Revenue by Application (2017-2022)
Table 16. Global Huntington Disease Protein Revenue Market Share by Application (2017-2022)
Table 17. Global Huntington Disease Protein Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Huntington Disease Protein Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Huntington Disease Protein Sales Market Share by Company (2020-2022)
Table 20. Global Huntington Disease Protein Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Huntington Disease Protein Revenue Market Share by Company (2020-2022)
Table 22. Global Huntington Disease Protein Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Huntington Disease Protein Producing Area Distribution and Sales Area
Table 24. Players Huntington Disease Protein Products Offered
Table 25. Huntington Disease Protein Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Huntington Disease Protein Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Huntington Disease Protein Sales Market Share Geographic Region (2017-2022)
Table 30. Global Huntington Disease Protein Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Huntington Disease Protein Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Huntington Disease Protein Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Huntington Disease Protein Sales Market Share by Country/Region (2017-2022)
Table 34. Global Huntington Disease Protein Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Huntington Disease Protein Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Huntington Disease Protein Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Huntington Disease Protein Sales Market Share by Country (2017-2022)
Table 38. Americas Huntington Disease Protein Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Huntington Disease Protein Revenue Market Share by Country (2017-2022)
Table 40. Americas Huntington Disease Protein Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Huntington Disease Protein Sales Market Share by Type (2017-2022)
Table 42. Americas Huntington Disease Protein Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Huntington Disease Protein Sales Market Share by Application (2017-2022)
Table 44. APAC Huntington Disease Protein Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Huntington Disease Protein Sales Market Share by Region (2017-2022)
Table 46. APAC Huntington Disease Protein Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Huntington Disease Protein Revenue Market Share by Region (2017-2022)
Table 48. APAC Huntington Disease Protein Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Huntington Disease Protein Sales Market Share by Type (2017-2022)
Table 50. APAC Huntington Disease Protein Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Huntington Disease Protein Sales Market Share by Application (2017-2022)
Table 52. Europe Huntington Disease Protein Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Huntington Disease Protein Sales Market Share by Country (2017-2022)
Table 54. Europe Huntington Disease Protein Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Huntington Disease Protein Revenue Market Share by Country (2017-2022)
Table 56. Europe Huntington Disease Protein Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Huntington Disease Protein Sales Market Share by Type (2017-2022)
Table 58. Europe Huntington Disease Protein Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Huntington Disease Protein Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Huntington Disease Protein Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Huntington Disease Protein Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Huntington Disease Protein Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Huntington Disease Protein Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Huntington Disease Protein Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Huntington Disease Protein Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Huntington Disease Protein Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Huntington Disease Protein Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Huntington Disease Protein
Table 69. Key Market Challenges & Risks of Huntington Disease Protein
Table 70. Key Industry Trends of Huntington Disease Protein
Table 71. Huntington Disease Protein Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Huntington Disease Protein Distributors List
Table 74. Huntington Disease Protein Customer List
Table 75. Global Huntington Disease Protein Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Huntington Disease Protein Sales Market Forecast by Region
Table 77. Global Huntington Disease Protein Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Huntington Disease Protein Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Huntington Disease Protein Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Huntington Disease Protein Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Huntington Disease Protein Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Huntington Disease Protein Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Huntington Disease Protein Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Huntington Disease Protein Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Huntington Disease Protein Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Huntington Disease Protein Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Huntington Disease Protein Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Huntington Disease Protein Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Huntington Disease Protein Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Huntington Disease Protein Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Huntington Disease Protein Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Huntington Disease Protein Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Huntington Disease Protein Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Huntington Disease Protein Revenue Market Share Forecast by Application (2023-2028)
Table 95. AFFiRiS AG Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 96. AFFiRiS AG Huntington Disease Protein Product Offered
Table 97. AFFiRiS AG Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. AFFiRiS AG Main Business
Table 99. AFFiRiS AG Latest Developments
Table 100. Ionis Pharmaceuticals, Inc. Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 101. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product Offered
Table 102. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Ionis Pharmaceuticals, Inc. Main Business
Table 104. Ionis Pharmaceuticals, Inc. Latest Developments
Table 105. Neurimmune Holding AG Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 106. Neurimmune Holding AG Huntington Disease Protein Product Offered
Table 107. Neurimmune Holding AG Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Neurimmune Holding AG Main Business
Table 109. Neurimmune Holding AG Latest Developments
Table 110. nLife Therapeutics, S.L. Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 111. nLife Therapeutics, S.L. Huntington Disease Protein Product Offered
Table 112. nLife Therapeutics, S.L. Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. nLife Therapeutics, S.L. Main Business
Table 114. nLife Therapeutics, S.L. Latest Developments
Table 115. reMYND NV Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 116. reMYND NV Huntington Disease Protein Product Offered
Table 117. reMYND NV Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. reMYND NV Main Business
Table 119. reMYND NV Latest Developments
Table 120. Sangamo BioSciences, Inc. Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 121. Sangamo BioSciences, Inc. Huntington Disease Protein Product Offered
Table 122. Sangamo BioSciences, Inc. Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. Sangamo BioSciences, Inc. Main Business
Table 124. Sangamo BioSciences, Inc. Latest Developments
Table 125. UniQure N.V. Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 126. UniQure N.V. Huntington Disease Protein Product Offered
Table 127. UniQure N.V. Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. UniQure N.V. Main Business
Table 129. UniQure N.V. Latest Developments
Table 130. Voyager Therapeutics, Inc. Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 131. Voyager Therapeutics, Inc. Huntington Disease Protein Product Offered
Table 132. Voyager Therapeutics, Inc. Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. Voyager Therapeutics, Inc. Main Business
Table 134. Voyager Therapeutics, Inc. Latest Developments
Table 135. Vybion, Inc. Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 136. Vybion, Inc. Huntington Disease Protein Product Offered
Table 137. Vybion, Inc. Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 138. Vybion, Inc. Main Business
Table 139. Vybion, Inc. Latest Developments
Table 140. WAVE Life Sciences Ltd. Basic Information, Huntington Disease Protein Manufacturing Base, Sales Area and Its Competitors
Table 141. WAVE Life Sciences Ltd. Huntington Disease Protein Product Offered
Table 142. WAVE Life Sciences Ltd. Huntington Disease Protein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 143. WAVE Life Sciences Ltd. Main Business
Table 144. WAVE Life Sciences Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Huntington Disease Protein
Figure 2. Huntington Disease Protein Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Huntington Disease Protein Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Huntington Disease Protein Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Huntington Disease Protein Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of NI-302
Figure 10. Product Picture of NLF-HD
Figure 11. Product Picture of P-301905
Figure 12. Product Picture of IONIS-HTTRx
Figure 13. Product Picture of Others
Figure 14. Global Huntington Disease Protein Sales Market Share by Type in 2021
Figure 15. Global Huntington Disease Protein Revenue Market Share by Type (2017-2022)
Figure 16. Huntington Disease Protein Consumed in Alzheimer's Disease
Figure 17. Global Huntington Disease Protein Market: Alzheimer's Disease (2017-2022) & (K Pcs)
Figure 18. Huntington Disease Protein Consumed in Kennedy's Disease
Figure 19. Global Huntington Disease Protein Market: Kennedy's Disease (2017-2022) & (K Pcs)
Figure 20. Huntington Disease Protein Consumed in Spinocerebellar Ataxia
Figure 21. Global Huntington Disease Protein Market: Spinocerebellar Ataxia (2017-2022) & (K Pcs)
Figure 22. Huntington Disease Protein Consumed in Others
Figure 23. Global Huntington Disease Protein Market: Others (2017-2022) & (K Pcs)
Figure 24. Global Huntington Disease Protein Sales Market Share by Application (2017-2022)
Figure 25. Global Huntington Disease Protein Revenue Market Share by Application in 2021
Figure 26. Huntington Disease Protein Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Huntington Disease Protein Revenue Market Share by Company in 2021
Figure 28. Global Huntington Disease Protein Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Huntington Disease Protein Revenue Market Share by Geographic Region in 2021
Figure 30. Global Huntington Disease Protein Sales Market Share by Region (2017-2022)
Figure 31. Global Huntington Disease Protein Revenue Market Share by Country/Region in 2021
Figure 32. Americas Huntington Disease Protein Sales 2017-2022 (K Pcs)
Figure 33. Americas Huntington Disease Protein Revenue 2017-2022 ($ Millions)
Figure 34. APAC Huntington Disease Protein Sales 2017-2022 (K Pcs)
Figure 35. APAC Huntington Disease Protein Revenue 2017-2022 ($ Millions)
Figure 36. Europe Huntington Disease Protein Sales 2017-2022 (K Pcs)
Figure 37. Europe Huntington Disease Protein Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Huntington Disease Protein Sales 2017-2022 (K Pcs)
Figure 39. Middle East & Africa Huntington Disease Protein Revenue 2017-2022 ($ Millions)
Figure 40. Americas Huntington Disease Protein Sales Market Share by Country in 2021
Figure 41. Americas Huntington Disease Protein Revenue Market Share by Country in 2021
Figure 42. United States Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Huntington Disease Protein Sales Market Share by Region in 2021
Figure 47. APAC Huntington Disease Protein Revenue Market Share by Regions in 2021
Figure 48. China Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Huntington Disease Protein Sales Market Share by Country in 2021
Figure 55. Europe Huntington Disease Protein Revenue Market Share by Country in 2021
Figure 56. Germany Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Huntington Disease Protein Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Huntington Disease Protein Revenue Market Share by Country in 2021
Figure 63. Egypt Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Huntington Disease Protein in 2021
Figure 69. Manufacturing Process Analysis of Huntington Disease Protein
Figure 70. Industry Chain Structure of Huntington Disease Protein
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Figure 1. Picture of Huntington Disease Protein
Figure 2. Huntington Disease Protein Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Huntington Disease Protein Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Huntington Disease Protein Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Huntington Disease Protein Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of NI-302
Figure 10. Product Picture of NLF-HD
Figure 11. Product Picture of P-301905
Figure 12. Product Picture of IONIS-HTTRx
Figure 13. Product Picture of Others
Figure 14. Global Huntington Disease Protein Sales Market Share by Type in 2021
Figure 15. Global Huntington Disease Protein Revenue Market Share by Type (2017-2022)
Figure 16. Huntington Disease Protein Consumed in Alzheimer's Disease
Figure 17. Global Huntington Disease Protein Market: Alzheimer's Disease (2017-2022) & (K Pcs)
Figure 18. Huntington Disease Protein Consumed in Kennedy's Disease
Figure 19. Global Huntington Disease Protein Market: Kennedy's Disease (2017-2022) & (K Pcs)
Figure 20. Huntington Disease Protein Consumed in Spinocerebellar Ataxia
Figure 21. Global Huntington Disease Protein Market: Spinocerebellar Ataxia (2017-2022) & (K Pcs)
Figure 22. Huntington Disease Protein Consumed in Others
Figure 23. Global Huntington Disease Protein Market: Others (2017-2022) & (K Pcs)
Figure 24. Global Huntington Disease Protein Sales Market Share by Application (2017-2022)
Figure 25. Global Huntington Disease Protein Revenue Market Share by Application in 2021
Figure 26. Huntington Disease Protein Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Huntington Disease Protein Revenue Market Share by Company in 2021
Figure 28. Global Huntington Disease Protein Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Huntington Disease Protein Revenue Market Share by Geographic Region in 2021
Figure 30. Global Huntington Disease Protein Sales Market Share by Region (2017-2022)
Figure 31. Global Huntington Disease Protein Revenue Market Share by Country/Region in 2021
Figure 32. Americas Huntington Disease Protein Sales 2017-2022 (K Pcs)
Figure 33. Americas Huntington Disease Protein Revenue 2017-2022 ($ Millions)
Figure 34. APAC Huntington Disease Protein Sales 2017-2022 (K Pcs)
Figure 35. APAC Huntington Disease Protein Revenue 2017-2022 ($ Millions)
Figure 36. Europe Huntington Disease Protein Sales 2017-2022 (K Pcs)
Figure 37. Europe Huntington Disease Protein Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Huntington Disease Protein Sales 2017-2022 (K Pcs)
Figure 39. Middle East & Africa Huntington Disease Protein Revenue 2017-2022 ($ Millions)
Figure 40. Americas Huntington Disease Protein Sales Market Share by Country in 2021
Figure 41. Americas Huntington Disease Protein Revenue Market Share by Country in 2021
Figure 42. United States Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Huntington Disease Protein Sales Market Share by Region in 2021
Figure 47. APAC Huntington Disease Protein Revenue Market Share by Regions in 2021
Figure 48. China Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Huntington Disease Protein Sales Market Share by Country in 2021
Figure 55. Europe Huntington Disease Protein Revenue Market Share by Country in 2021
Figure 56. Germany Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Huntington Disease Protein Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Huntington Disease Protein Revenue Market Share by Country in 2021
Figure 63. Egypt Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Huntington Disease Protein Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Huntington Disease Protein in 2021
Figure 69. Manufacturing Process Analysis of Huntington Disease Protein
Figure 70. Industry Chain Structure of Huntington Disease Protein
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
